P A Paglini-Oliva
Overview
Explore the profile of P A Paglini-Oliva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
20
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lo Presti M, Rivarola H, Bustamante J, Fernandez A, Enders J, Fretes R, et al.
Int J Antimicrob Agents
. 2004 Jun;
23(6):634-6.
PMID: 15194137
Trypanosoma cruzi trypanothione reductase is an enzyme that has been identified as a potential target for chemotherapy. Thioridazine inhibits it and prevented cardiopathy in mice infected with T. cruzi Tulahuen...
2.
Bustamante J, Rivarola H, Palma J, Paglini-Oliva P
Parasitology
. 2004 May;
128(Pt 4):415-9.
PMID: 15151147
Chagas' disease, caused by Trypanosoma cruzi, affects approximately 20 million people. There are 3 stages in the disease: acute, intermediate and chronic, the diversity and severity of the symptoms range...
3.
Rivarola H, Paglini-Oliva P
Curr Drug Targets Cardiovasc Haematol Disord
. 2003 May;
2(1):43-52.
PMID: 12769656
Chagas' disease affects about 18 million people and 25% of the population of Latin America is at risk of acquiring Chagas' disease. The chemotherapy of Chagas' disease is still an...